RotaTeq
Proper Name: Rotavirus Vaccine, Live, Oral, Pentavalent
Tradename: RotaTeq
Manufacturer: Merck & Co, Inc, License #0002
Indication:
For prevention of rotavirus gastroenteritis in infants and children caused by the serotypes G1, G2, G3, and G4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks.
open here to see the full-text:
Approved Products RotaTeq
.png)
No hay comentarios:
Publicar un comentario